WhitePaper RBM for Mid-sized CROs

Recent research shows, the size of sponsors correlates with the size of service providers. Big Pharma relies on the large, full-service CROs if they are running a large clinical trial.

As the outsourcing world has always moved in cycles, today, there is a chance to change the situation. Mid-sized CROs can demonstrate to sponsors their experience and provide an evidence-based proof of expertise, needed to win a bigger project, e.g., multinational phase III trial.

Embracing RBM, a company’s smaller size can become an advantage.

Read more and download the White Paper